| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| Gene symbol | IL18 | Synonyms | IGIF, IL-18, IL-1g, IL1F4 | Type of gene | protein-coding |
| Chromosome | 11 | Map location | 11q23.1 | dbXrefs | |
| Gene perturbation-related omics dataset | PertOrg | ||||
| Description | interleukin 18 | ||||
| GTO ID | GTC3547 |
| Trial ID | NCT05989204 |
| Disease | Non-Hodgkin's Lymphoma |
| Altered gene | CD19|IL-18 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | TmCD19-IL18 |
| Phase | Phase1 |
| Recruitment status | Recruiting |
| Title | Phase I Trial of TmCD19-IL18 CAR T Cells in Patients With Relapsed or Refractory CD19+ Cancers |
| Year | 2023 |
| Country | United States |
| Company sponsor | University of Pennsylvania |
| Other ID(s) | UPCC 12423 |
| Cohort 1 | |||||||||||
|
|||||||||||